| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/05/2009 | US20090060909 Antibody antagonists of ve-cadherin without adverse effects on vascular permeability |
| 03/05/2009 | US20090060908 antibodies exhibit increased antibody-dependent cellular cytotoxicity activity; humanizing, chimera |
| 03/05/2009 | US20090060907 Antibody against secreted N-terminal peptide of GPC3 present in blood or C-terminal peptide of GPC3 |
| 03/05/2009 | US20090060906 Anti-IL-13 antibody formulations and uses thereof |
| 03/05/2009 | US20090060905 Use of 15-Lipoxygenase Inhibitors for Treating Obesity |
| 03/05/2009 | US20090060904 Vegetarian Protein A Preparation and Methods Thereof |
| 03/05/2009 | US20090060903 administering Noggin proteins to reduce teratogenicity of antineoplastic agents; antibodies |
| 03/05/2009 | US20090060902 Methods and compositions for regulating T cell subsets by modulating transcription factor activity |
| 03/05/2009 | US20090060901 Detoxification method |
| 03/05/2009 | US20090060900 Methods for Screening Compounds That Modulate Lipid Metabolism |
| 03/05/2009 | US20090060899 Composition of organic compounds |
| 03/05/2009 | US20090060898 Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response |
| 03/05/2009 | US20090060875 HCV Vaccines for Chronic HCV Patients |
| 03/05/2009 | US20090060874 Bicyclic pyrrolidine derivatives |
| 03/05/2009 | US20090060873 Novel synthetic triterpenoids and methods of use in the treatment and prevention of multiple scleroris |
| 03/05/2009 | US20090060870 for treatment of virally induced intraepithelial neoplasias of the ano-genital tract, such as human papilloma virus-induced vulvar-, cervical-, vaginal-, penile- and anal intraepithelial neoplasias; measuring or detecting the presence of a CD4+ type 1 T helper (Th1) cell response against an HPV |
| 03/05/2009 | US20090060869 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 03/05/2009 | US20090060865 Mammalian receptor proteins; related reagents and methods |
| 03/05/2009 | US20090060864 administering an antitumor agent containing a combination of an alpha v beta 3 angiogenisis antagonist and an anti-tumor immunotherapeutic agent, which is a fusion protein of a cytokine IL-2 and an Ig heavy chain that immunoreacts with a tumor associated antigen target; drug target |
| 03/05/2009 | CA2715305A1 Methods and compositions for modulating t cells |
| 03/05/2009 | CA2698146A1 Anti-epha2 antibody |
| 03/05/2009 | CA2698129A1 Prophylactic or alleviating agent for peripheral nerve disorder induced by anti-cancer agent |
| 03/05/2009 | CA2697976A1 A process for producing a peptide hormone |
| 03/05/2009 | CA2697729A1 Influenza antigen delivery vectors and constructs |
| 03/05/2009 | CA2697513A1 Ebi3, dlx5, nptx1 and cdkn3 for target genes of lung cancer therapy and diagnosis |
| 03/05/2009 | CA2697378A1 A modulator of nrg1 for treatment of respiratory disorders |
| 03/05/2009 | CA2697373A1 Immunogenic compositions and methods |
| 03/05/2009 | CA2697370A1 Hiv env proteins with modifications in the v3 loop |
| 03/05/2009 | CA2697363A1 Modulation of synaptogenesis |
| 03/05/2009 | CA2697070A1 Methods of inhibiting tumor growth using beta 5 integrin antagonists |
| 03/05/2009 | CA2696090A1 Method for producing viral vaccines |
| 03/05/2009 | CA2687681A1 Antigen-binding proteins targeting s. aureus orf0657n |
| 03/04/2009 | EP2031075A1 Molecular differences between species of the M. Tuberculosis complex |
| 03/04/2009 | EP2031065A1 A recombinant koi herpesvirus (KHV) or Cyprinid herpesvirus 3 (CyHV-3) and a vaccine for the prevention of a disease caused by KHV/CyHV-3 in Cyprinus carpio carpio or Cyprinus carpio koi |
| 03/04/2009 | EP2029756A1 Process for producing poxviruses and poxvirus compositions |
| 03/04/2009 | EP2029748A2 N protein fusion proteins of a virus in the paramyxoviridae-protein of interest family and their uses for vaccination and intra-cellular vectorisation |
| 03/04/2009 | EP2029729A2 Methods of using anti-thymocyte globulin and related agents |
| 03/04/2009 | EP2029628A2 Antibodies selectively binding aggregated prion protein 106-126 and uses thereof |
| 03/04/2009 | EP2029627A2 Hepatocyte growth factor (hgf) binding proteins |
| 03/04/2009 | EP2029624A1 Peptide associated with rheumatic fever (parf) and its use as a diagnostic marker |
| 03/04/2009 | EP2029621A2 Blood-brain barrier targeting antibodies |
| 03/04/2009 | EP2029176A2 Viral capsid proteins and any peptides or compositions thereof for the treatment of pathologic disorders |
| 03/04/2009 | EP2029173A2 Fc riib-specific antibodies and methods of use thereof |
| 03/04/2009 | EP2029172A2 Anti-c35 antibodies for treating cancer |
| 03/04/2009 | EP2029171A1 Methods of modulating il-22 and il-17 |
| 03/04/2009 | EP2029170A2 Quality control methods for oil-in-water emulsions containing squalene |
| 03/04/2009 | EP2029169A2 Recombinant viral vaccine |
| 03/04/2009 | EP2029168A2 Hiv-1 clade a consensus sequences, antigens, and transgenes |
| 03/04/2009 | EP2029167A2 Novel dna sequences, vectors and proteins of avian influenza hemagglutinin |
| 03/04/2009 | EP2029166A2 Vaccination of young animals against lawsonia intracellularis infections |
| 03/04/2009 | EP2029165A1 B cell-based vaccine loaded with the ligand of natural killer t cell and antigen |
| 03/04/2009 | EP2029164A2 Anti-leukocyte recruitment therapy for the treatment of seizures and epilepsy |
| 03/04/2009 | EP2029163A2 Lyophilized formulations of anti-egfr antibodies |
| 03/04/2009 | EP2029159A2 Compositions and methods for modulating vascular development |
| 03/04/2009 | EP1706486B1 Chimeric empty capsids of the infectious bursal disease virus (ibdv), obtainment process and applications |
| 03/04/2009 | EP1551812B1 Mitotic kinesin inhibitors |
| 03/04/2009 | EP1519957B1 Use of hmgb1 in the treatment of tissue damage and/or to promote tissue repair |
| 03/04/2009 | EP1432738B1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 03/04/2009 | EP1414494B1 Inhibitory antibodies of her3 activity |
| 03/04/2009 | EP1294876B1 Eg-vegf nucleic acids and polypeptides and methods of use |
| 03/04/2009 | EP1255845B1 Modified cytokines for use in cancer therapy |
| 03/04/2009 | EP1246917B1 Human stra6 polypeptides |
| 03/04/2009 | EP1181366B1 Mammalian receptor proteins; related reagents and methods |
| 03/04/2009 | EP1078006B1 Diagnosis and treatment of hepatic disorders |
| 03/04/2009 | EP1037918B1 Compositions to enhance the efficacy of a vaccine using chemokines |
| 03/04/2009 | EP1019085B1 Non-anaphylactic forms of allergens and their use |
| 03/04/2009 | EP0988054B1 Method and compositions for preventing and treating the systemic inflammatory response syndrome including sepsis |
| 03/04/2009 | CN101379397A Monoclonal antibody for H5 subtype fowl-influenza virus hemagglutinin protein or combined active fragment, and uses thereof |
| 03/04/2009 | CN101379192A Anti-Met monoclonal antibody, fragments and vectors thereof, for the treatment of tumors and corresponding products |
| 03/04/2009 | CN101379183A Rescue of influenza virus |
| 03/04/2009 | CN101379089A Anti-ILT7 antibody |
| 03/04/2009 | CN101379087A Compositions and methods for the treatment of diseases and disorders associated with cytokine signaling |
| 03/04/2009 | CN101379086A Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders |
| 03/04/2009 | CN101379084A Novel anticoagulant polypeptides and complex |
| 03/04/2009 | CN101379078A Treatment of Epstein-Barr virus-associated diseases |
| 03/04/2009 | CN101378781A Compositions and methods for production of immunoglobulins |
| 03/04/2009 | CN101378780A Colonization factor (CF) antigens of enterotoxigenic escherichia coli in recombinant bacteria |
| 03/04/2009 | CN101378779A Vaccine |
| 03/04/2009 | CN101378778A Vaccine comprising streptococcus pneumoniae capsular polyaccharide conjugates |
| 03/04/2009 | CN101378777A Novel vaccine carrier |
| 03/04/2009 | CN101378776A Novel synthetic agonists of TOll-like receptors containing CG dinucleotide modifications |
| 03/04/2009 | CN101376891A Preparation of novel tuberculosis vaccine and use thereof |
| 03/04/2009 | CN101376887A Preparation and use of swine foot-and-mouth disease recombinant immune composite peptide |
| 03/04/2009 | CN101376880A Recombinant new castle disease LaSota attenuated vaccine strain expressing rabies virus glucoprotein (GP protein) |
| 03/04/2009 | CN101376878A Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby |
| 03/04/2009 | CN101376027A Recombined newcastle disease virus LaSota attenuated vaccine strain for expressing avian influenza virus H9 subtype HA protein |
| 03/04/2009 | CN101376026A Method for preparing vaccine of porcine circovirus type 2 |
| 03/04/2009 | CN101376025A Bacillus tubercle gene vaccine for treating medicine-tolerant pulmonary tuberculosis |
| 03/04/2009 | CN101376024A Agent for protecting pig mycoplasma vaccine and promoting absorption as well as production method and use method thereof |
| 03/04/2009 | CN101376023A Vaccine sustained-release agent for birds as well as preparation and inoculation method thereof |
| 03/04/2009 | CN100465280C A chicken RNA polymerisate I promoter and an application thereof |
| 03/04/2009 | CN100464782C A therapeutic agent for fibromyalgia |
| 03/03/2009 | US7498420 Human monoclonal antibody for use in the diagnosis prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 03/03/2009 | US7498419 Crystals and structure of domain III of West Nile Virus envelope protein in association with a Fab fragment of a neutralizing antibody |
| 03/03/2009 | US7498417 Comprises nucleotide sequences coding cell growth factors for use in developing modulators for treatment of cell proliferative, arthritic, skin and vision defects; immunotherapy |
| 03/03/2009 | US7498416 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 03/03/2009 | US7498414 Comprising complementarity determining regions; recombinant host cells; fab fragments, fv fragments, diabodies, triabodies, and single domain antibodies; angiogenesis inhibitors; antitumor, antiproliferative, and anticarcinogenic agents; gene expression |
| 03/03/2009 | US7498407 Vascular endothelial cell growth inhibitor, VEGI-192a |
| 03/03/2009 | US7498304 Angiogenesis-modulating compositions and uses |
| 03/03/2009 | US7498302 Analogues of rachelmycin and the duocarmycins that are potent cytotoxins containing a benzodipyrrole or naphthopyrrole ring; anticancer agents |